# Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection

> **NCT02767375** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 192 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Oxaliplatin(OXA), 5-fluorouracil (5-FU)
- **PROCEDURE:** Hepatic arterial catheter implantation

## Key facts

- **NCT ID:** NCT02767375
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2017-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02767375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02767375, "Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02767375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*